This study assessed the effects of statins on preventing clinical events associated with cardiovascular disease (CVD). The authors concluded that there was a considerable reduction in risk of CVD morbidity and mortality in people with CVD, and a small reduction in risk in those without CVD.
Methods of synthesis
How were the studies combined? The RRs were pooled using a fixed-effect model if there was no evidence of heterogeneity, otherwise a random-effects model was used. For the meta-analysis, where no event was recorded 0.5 was added to the tables.
How were differences between studies investigated?
Heterogeneity was assessed using the chi-squared test, where a P-value of less than 0.05 was taken to indicate statistical significance. Sensitivity analyses were performed by removing individual studies from the analyses.
Results of the review
Fifteen studies (63,410 participants) were included. Of these 4 studies (14,566 participants) were primary prevention, 10 studies (28,308 participants) were secondary prevention and one study (20,536 participants) was mixed (primary and secondary prevention).
Tests for heterogeneity showed little variability between studies so fixed-effect analyses were reported. Not all studies reported on all outcomes.
Primary prevention.
The use of statins reduced the risk of cardiovascular mortality (RR 0.66, 95% CI: 0.49, 0.90, P=0.0082) and of having a coronary event (RR 0.67, 95% CI: 0.58, 0.77, P<0.0001). There was no difference in non-cardiovascular mortality between the statins and placebo groups (RR 1.03, 95% CI: 0.80, 1.33, P=0.8026). There was no evidence of an effect on fatal stroke, nonfatal stroke or total stroke. The effect on all-cause mortality was non significant (RR 0.86, 95% CI: 0.72, 1.04, P=0.1303). The effect on non-CVD mortality or fatal stroke did not reach statistical significance (P=0. 1677 and P=0.1912, respectively) . Statin use was associated with a 22% reduction in total cholesterol, a 29% reduction in LDL cholesterol, a 12% reduction in triglycerides and a 6% increase in HDL cholesterol. Different statins appeared to have similar effects on cholesterol levels. The results were not altered when individual studies were removed from the analyses.
